Lower arrythmogenic risk of low dose albuterol plus ipratropium

Indian Journal of Pediatrics

Volumn 68, Issue 10, 2001, Pages 945-949

  Yuksel, Hasan ^a,b   Coskun, Senol ^a   Polat, Muzaffer ^a   Onag, Ali ^a  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^b NONE   (Turkey)

Author keywords

Albuterol; Arrhythmia; Ipratropium bromide; QT dispersion; Wheezy infant

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; SALBUTAMOL; VENTOLIN NEBULE;

ARRHYTHMOGENESIS; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG SAFETY; FEMALE; HEART ARRHYTHMIA; HIGH RISK POPULATION; HUMAN; MALE; OXYGEN SATURATION; OXYGENATION; PRESCHOOL CHILD; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; RISK FACTOR; TREATMENT PLANNING; WHEEZING;

EID: 0035196921     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02722593     Document Type: Article

References (35)

1. Martinez FD. Asthma phenotypes: wheezy infants and wheezy children. Immunol Aller Clin North Am 1998; 18 : 25-33.
2. Sutherland DC, Wilson JD. Theophylline, beta agonist and fatal asthma. Lancet 1981; 1 : 988.
3. Azevado I, de Blinc J, Scheinmann P, Vargaftic B, Bachelet M. Enhanced arachidonic acid metabolism in alveolar macrophages from wheezy infants. Am J Respir Crit Care Med 1995; 152 : 1208-1214.
4. Eisen A, Bacal H. Relationship of acute bronchiolitis to bronchial asthma: a 4-14 year follow-up. Pediatrics 1963; 31 : 859.
5. Woter K, Henry M, Stewart P et al. Lower respiratory illness in early childhood and lung function and bronchial reactivity in adolescent males. Am Rev Respir Dis 1988; 137 : 302.
6. Morgan WJ, Martinez FD. Risk factors for developing wheezing and asthma in childhood. Pediatr Clin North Am 1992; 39 : 1185-1205.
7. Bentur L, Canny GJ, Shields MD, Kerem E, Schuh S, Reisman JJ et al. Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma. Pediatrics 1992; 89 : 133-137.
8. Tepper R. Airway reactivity in infants: A positive rsponse to methacoline and metaproterenol. J Appl Physiol 1987; 62 : 1155.
9. Stempel DA, Redding GJ. Menagement of acute asthma. Pediatr Clin North Am 1992; 39 : 1311-1327.
10. Sarubbi B, Esposito V, Duccesschi VV et al. Effect of blood gas derangement on QTc dispersion in severe chronic obstructive pulmonary disease : evidence of an electropathy ? Int J Cardiol 1997; 58 : 287-292.
11. Conradson TB, Eklundh G, Olofsson B et al. Cardiac arrhythmias in patients with mild-to-moderate obstructive pulmonary disease : comparison of beta agonist therapy alone and in combination with a xanthine derivative, enprophylline or theophylline. Chest 1985; 88 : 537-542.
12. Ben-Zvi Z, Lam C, Hoffman J, Teets-Grimn KC, Kattan M. Evaluation of initial management of acute asthma. Pediatrics 1982; 70 : 348-353.
13. Vaughan Williams EM. Cardiac electrophysiologic effects of selective adrenoceptor stimulation and their possible roles in arrhythmias. J Cardiovasc Pharmacol 1985; 7 : S61-64.
14. Kiely DG, Cargill RI, Grove A, Struthers AD, Lipworth BJ. Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. Thorax 1995; 50(10) : 1062-1066.
15. Pye M, Quinn AC, Cobbe SM. QT interval dispersion : a non- invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias ? Br Heart J 1994; 71: 511-514.
16. National Asthma Education and Prevention Programme. Expert Panel Report-2. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD, February 1997.
17. Katz RW, Kelly HW, Crowley MR, Grad R. Safety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics 1993; 92 (5) : 666-669.
18. Finn AF Jr, Thompson CM Jr, Banov CH, O'Connor BK. Case CL. ß-2 agonist induced ventricular dysrhythmias secondary to hyperexcitable conduction system in the absence of a long QT syndrome. Ann Allerg Asthma Immunol 1997; 78(2) : 230-232.
19. Lin RY, Smith AJ, Hergenroeder P. High serum albuterol levels and tachycardia in adult asthmatics with high-dose continuously aerosolized albuterol. Chest 1993; 10333 (1) : 221-225.
20. Crane J, Pearce N, Flatt A et al. Prescribed fenoterol and death from asthma in New Zealand 1981-83: case-control study. Lancet 1989; 1 : 917-922.
21. Pearce N, Grainger J, Atkinson M et al. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax 1990; 45 : 170-175.
22. Grainger J, Woodman K, Pearce N et al. Prescribed fenoterol and death from asthma in New Zealand 1981-87: a further case-control study. Thorax 1991; 466 : 105-111.
23. Davis A, Vickerson V, Worsley G, Mindorff C, Kazim F, Levison H. Determination of dose response relationship for nebulized ipratropium in asthmatic children. J Pediatr 1984; 105 : 1002-1005.
24. Lehrer PM, Hochron SM, Rausch L, Carr R. Effects of aerosol ipratropium bromide on cardiac vagal tone. Chest 1994; 105(6) : 1701-1704.
25. Rubin BK, Albers GM. Use of anticholinergic bronchodilatation in children. Am J Med 1996; 100 (Suppl 1) : 49-53.
26. Bierman CW, Pierson WE. The pharmacologic management of status asthmaticus in children. Pediatrics 1974; 54 : 245.
27. Fei L, Statters DJ, Camm AJ. QT interval dispersion on 12 lead electrocardiogram in normal subjects. Its reproducibility and relation to the T wave. Am Heart J 1994; 127 : 1654-1665.
28. Jenne JW. Physiological actions of beta-adrenergic agonists. In Leff AR, eds. Pulmonary and Critical Care Pharmacology and Therapeutics. New York: McGraw Hill. 1996; 473-487.
29. Viegas CA, Ferrer A, Montserrat JM et al. Ventilation-perfusion response after fenoterol in hypoxaemic patients with stable COPD. Chest 1996; 110 : 71-77.
30. Gorecka D. Cardiac arrhythmias in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1997; 52 : 278-281.
31. Steward AG, Waterhouse JC, Howard T. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. Respir Med 1995; 89 : 79-84.
32. Higham PD, Campbell RWF. QT dispersion. Br Heart J 1994; 71 : 508-510.
33. Bremmer P, Woodman K, Burgess C et al. A comparison of cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. Eur Respir J 1993; 6 (2) : 204-210.
34. Castro A, Pandozi C, Bianconi L, Toscano S, Santini M. Latent long QT syndrome : description of a clinical case. G Ital Cardiol 1997; 27 : 374-379.
35. Naspitz CK, Sole D. Treatment of acute wheezing and dyspnea attacks in children under two years old : inhalation of feneterol plus ipratropium-bromide versus feneterol. J Asthma 1992; 29 : 253-258.